TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / ADC Therapeutics Stock

ADC Therapeutics Stock

adctherapeutics.comHealthcareFunding to Date: $200.02MM

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Learn more about ADC Therapeutics IPO
Register for Details

For more details on financing and valuation for ADC Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for ADC Therapeutics.

Register Today

Team

Management Team

Susan Romanus
Chief Compliance Officer
Stéphane Henchoz
Director, Finance
David Ellis Ph.D
Head of Global Regulatory Affairs
Patrick Van Berkel Ph.D
Senior Vice President, Research & Development
Michael Forer
Vice Chairman, Executive Vice President & Chief Financial Officer
Maria Cincotta
Head of Global Clinical Science and Operations
Jay Feingold Ph.D
Chief Medical Officer, Senior Vice President Head of Oncology Clinical Development
Richard Warburg Ph.D
Head, Intellectual Property
Chris Martin Ph.D
Chief Executive Officer & Board Member
Michael Mulkerrin Ph.D
Head of Chemistry Manufacturing and Control & Vice President
Esohe Idusogie Ph.D
Head of Process Quality and CMC Analytical
Richard Onyett
Vice President, Business Development

Board Members

Chris Martin Ph.D
Jacques Theurillat
Peter Corr Ph.D
Auven Therapeutics
Thomas Pfisterer
Wild Family Office
Barrie Ward Ph.D
Stephen Evans-Freke
Auven Therapeutics
Tyrell Rivers Ph.D
Peter Hug Ph.D
Thomas Rinderknecht Ph.D

Other companies like ADC Therapeutics in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

Trending Companies

Frequently Asked Questions